Overview
Exciting opportunity for a motivated research fellow to join the Hodi Lab.
We are seeking a highly-motivated Postdoctoral Fellow who will lead the investigation and be responsible for the conduct of laboratory based research in immune therapy for cancer.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow’s physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where we provide compassionate and comprehensive care to patients of all backgrounds, and design programs to promote public health particularly among high-risk and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow’s physician/researchers, and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Responsibilities
The project will investigate the role of angiogenesis in immune regulation and homing. This work will strive to improve understanding of the interplay of angiogenesis and immune checkpoint blockade as well as other immune therapy interventions. Much of the project focus will involve the role of tumor endothelium as the gatekeeper to the tumor microenvironment and immune regulation. This work involves skills that include sterile tissue culture, performing immunologic screens for novel targets, and validating novel biologically-based therapeutic targets. The development of novel immunologic techniques and applying novel technologies will be included in this effort. Collaboration with pathologists for correlations with tissue imaging and with computational biologists is expected. Much of the work will include utilization of human tissues and samples for in vitro work and modeling. In addition, some animal work may be involved.
Qualifications
Ph.D or M.D in biology or related field required.
The successful candidate will be very organized, a team player and able to work flexible hours in order to accommodate experimental needs. We are looking for a bright, motivated, dedicated individual with strong scientific, organizational and inter-personal skills. The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases
At Dana-Farber Cancer Institute, we work every day to create an innovative, caring, and inclusive environment where every patient, family, and staff member feels they belong. As relentless as we are in our mission to reduce the burden of cancer for all, we are equally committed to diversifying our faculty and staff. Cancer knows no boundaries and when it comes to hiring the most dedicated and diverse professionals, neither do we. If working in this kind of organization inspires you, we encourage you to apply.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics protected by law.
